PRQR (ProQR Therapeutics NV) Earnings per share increase in current year
ProQR Therapeutics N.V. (PRQR) monetizes its Axiomer platform through licenses for pharma behemoths, eliminating capital expenditures. This GURU.Markets terminal chart on annual EPS growth, where this metric equals -0.80, links these successes to RNA editing patents. Stable partner cash flows from intellectual property provide liquidity, transforming the technology stack into a reliable cash generator.
Analytical breakdowns and data insights for company ProQR Therapeutics (PRQR)
- share price and expert price forecast:
- business market valuation indicators:
- business book valuation details:
- debt burden and liquidity indicators:
- company profitability and valuation multiples indicators:
PRQR - Net Profit|Company Profit Forecast ProQR Therapeutics N.V.|PRQR - P/E Multiple|Projected Price to Earnings ProQR Therapeutics NV|PRQR - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio ProQR|PRQR - Operating profit before deduction of amortization|Earnings per share for the trailing year ProQR Therapeutics N.V.|PRQR - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months proqr.com|PRQR - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year ProQR Therapeutics N.V.
- revenue and sales proceeds data:
Fundamental valuation:PRQR ProQR Therapeutics
ProQR Therapeutics N.V. (PRQR) focuses on developing innovative RNA-based therapies for hereditary pathologies, making financial stability critical for the continuation of its research. By analyzing the annual growth of earnings per share, an investor can see the percentage deviation of the current EPS from the previous year's value, which allows for an assessment of capital management efficiency and the management's ability to monetize scientific developments amid industry volatility.
Key competitors
Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|NTLA: Earnings per share increase in current year|Net earnings per share growth this year STOK (Stoke Corp)|Expected net earnings per share growth this year biolifesolutions.com|Earnings growth in current year WVE (Wave Life Sciences Ltd)|Expected net earnings per share growth this year Maze Therapeutics (MAZE)|SION: Net earnings per share growth this year|Expected net earnings per share growth this year Prime Medicine Bio PRME|TSHA: Earnings growth in current year|Earnings per share growth this year QURE|Net earnings per share growth this year MGTX|Earnings per share growth this year RGNX (REGENXBIO)|Earnings growth in current year SLDB|OCGN - Earnings per share growth rate in current year|Earnings per share growth in current year Pacific Biosciences of California PACB|BNTC: Earnings per share growth this year|DSGN - Earnings per share growth in current year|RCKT: Earnings per share growth in current year|FDMT - Net earnings per one share growth for the current year|Earnings per share growth rate in current year Lexeo Therapeutics Inc. (LXEO)|Earnings per share growth in current year Korro Bio Inc.|Editas Medicine (EDIT) - Expected net earnings per share growth this year|Earnings per share growth in current year Silence Therapeutics Inc. (SLN)|Codexis - Earnings per share growth this year|Earnings growth in current year SGMO (Sangamo Therapeutics)|Earnings growth in current year nautilus.bio NAUT|Metagenomi Inc. - Earnings growth in current year|DTIL (Precision BioSciences Inc.) - Earnings per share growth this year|GBIO: Earnings growth in current year|Earnings per share growth rate in current year Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Earnings growth in current year|Net earnings per share growth this year Imunon (IMNN)|Earnings growth in current year PHIO|Mustang Bio - Earnings per share growth this year|TransCode Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Bionano Genomics, Inc. (BNGO)|APDN - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year
